Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)
关键词
抽象
描述
The BEATLES study is an investigator-initiated, prospective, double-blinded, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity-related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesity combining a lifestyle program and a minimally invasive, angiographic (i.e., through blood vessels) approach.
日期
最后验证: | 02/29/2020 |
首次提交: | 12/10/2019 |
提交的预估入学人数: | 12/11/2019 |
首次发布: | 12/12/2019 |
上次提交的更新: | 03/18/2020 |
最近更新发布: | 03/19/2020 |
实际学习开始日期: | 01/09/2020 |
预计主要完成日期: | 11/30/2023 |
预计完成日期: | 11/30/2023 |
状况或疾病
干预/治疗
Device: Bariatric Embolization Procedure
Other: Control Arm
相
手臂组
臂 | 干预/治疗 |
---|---|
Sham Comparator: Control Arm 27 participants enrolled in the procedure arm. Participants randomized to the control arm will follow the same screening. Pre-procedure assessment will take the same pre-procedure meds. Procedure day, interventional radiologist will determine radial or groin access. After the participant and procedure area are prepped, participants will be under standard moderate sedation medications; all participants will receive lidocaine & a skin nick to their groin or their wrist as determined by the operating physician. Participant will have a blind fold placed & their hearing damped either with ear plugs or noise cancelling headphones. Participants randomized to the control arm will not receive other procedural intervention. Procedural team will follow a prescribed simulated protocol. Participants randomized to the control arm will be given under skin lidocaine and receive a skin nick on the wrist or groin. | Other: Control Arm Participants randomized to the control arm will follow the same screening and pre-procedure assessment, and will also take the same pre-procedure medications. The procedural team instead will follow a prescribed simulated protocol that will mimic an actual embolization procedure. |
Active Comparator: Bariatric Embolization Procedure 27 subjects will be enrolled in the bariatric embolization(BM) procedure arm. BM procedure will be performed under moderate sedation. Procedure will take 1.5 hr to 3 hr subject will be placed on the X-ray fluoroscopy table. Radial or femoral vascular access will be achieved using a small gauge needle, dilated over a guidewire to accommodate a 5 French vascular sheath. Standard catheters, 3 dimensional imaging will be acquired of the stomach, the arteries supplying the fundus arising off the celiac vessel. Microcatheter into the left gastric and/or gastroepiploic arteries supplying the fundus and small calibrated spheres will be infused until stasis of anterograde arterial flow is achieved, with particular care to avoid infusion of non-target arteries. The left gastric and/or gastroepiploic arteries will be embolized. Repeat 3 dimensional imaging: assess bead distribution and fundal coverage. Subject will be monitored in the recovery room and will be observed overnight. | Device: Bariatric Embolization Procedure The BEATLES study is an investigator-initiated, prospective, doubleblind, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesity combining a lifestyle program and a minimally invasive, angiographic (i.e., through blood vessels) approach. |
资格标准
有资格学习的年龄 | 21 Years 至 21 Years |
有资格学习的性别 | All |
接受健康志愿者 | 是 |
标准 | Inclusion Criteria: - Male or female, aged ≥21 and ≤70 years - Willing, able, and mentally competent to provide written informed consent - Obese patients with a BMI ≥35 kg/m2 - Weight ≤400 lb - Vascular anatomy (including celiac, hepatic, and gastric arteries) that in the opinion of the interventional radiologist is amendable to bariatric embolization, as assessed via 3D CT angiography - Suitable for protocol therapy, as determined by the interventional radiology investigator - Adequate hematologic (neutrophils>1.5x109/L, platelets>70x109/L, INR<1.5), hepatic (bilirubin≤2.0mg/dL, albumin≥2.5g/L), and renal (estimated GFR>60mL/min. 1.73m2) function - For females of reproductive potential: agreement to use of highly effective contraception - for duration of study participation - Patients who have failed conservative weight loss therapies such as supervised low calorie diets combined with behavior therapy and exercise - Live or work within 65 miles of the enrolling institution in case a catastrophic post embolization event occurs Exclusion Criteria: - hemoglobin A1c greater than 8% - Patients who are currently taking either Insulin or sulfonylurea (medication changes are allowed) - Prior history of gastric, pancreatic, hepatic, and/or splenic surgery - Prior radiation therapy to the upper abdomen - Prior embolization to the stomach, spleen, or liver - Cirrhosis - Known portal venous hypertension - Active peptic ulcer disease - Significant risk factors for peptic ulcer disease, including daily NSAID use - Large hiatal hernia, defined as >5 cm in size - Active H. Pylori infection - Known aortic pathology, such as aneurysm or dissection - Renal insufficiency, as evidenced by an estimated glomerular filtration rate of <60 mL/min - Major comorbidity, such as active cancer, significant cardiovascular disease, or peripheral arterial disease - Pregnancy - Pre-existing chronic abdominal pain - Positive stool occult blood study - GI bleeding or bleeding diathesis within 5 years - Weight loss (intentional or unintentional) of more than or equal to 5% of body weight in the 6 months prior to randomization - A weight loss greater than 6lb during the weight management run- in - Endoscopic findings that would preclude bariatric embolization (at the discretion of the study team) - History of gastric motility disorders or an abnormal nuclear gastric motility examination (to be performed in diabetic subjects only) - American Society of Anesthesiologists Class 4 or 5 (very high risk surgical candidates: class 4=incapacitating disease that is a constant threat to life) at the time of screening for enrollment into the study - this exclusion criterion exists, because of the possibility that surgical intervention will be needed if the study intervention subsequently leads to severe adverse effects - Inflammatory bowel disease - Autoimmune disease or HIV+ - History of allergy to iodinated contrast media - Failure to comply with pre-procedure weight management "run-in", or other pre-procedural visits (specifically, participants must complete 80% of weight management and Lose It! Food tracking, and 100% of one-time visits, i.e. MRI, CTA, endoscopy) - Applicability of any contraindication regarding patient's vasculature as per Instruction for Use - Inability to have an MRI scan (i.e., metal implants or claustrophobia) - Smokers/vape users/tobacco use - Active or new-onset endocrine disorders (stable disease acceptable) - Other unforeseen conditions that may make patients unsuitable for the procedure (study team discretion) Exclusion Criteria (Psychiatric): - As determined by clinical judgment based on Clinical Interview, psychological/behavioral measures, medical records, previous mental health records/other collateral information (as available) and consistent with DSM -5 criteria: - Diagnosis of severe mental illness (i.e., chronic psychotic spectrum disorders, clinically significant mood disorders) AND/OR one or more of the following: - Evidence of active relapse or active impairing symptoms (e.g., suicidal ideation, audio or visual hallucinations, paranoia, thought disturbance, severe impairment) - Evidence of minimal supports or limited adherence to ongoing mental health care - Failure to provide comprehensive aftercare plan that includes emergency plan for addressing future mental health relapse - History of treatment refractory mental illness/recurrent relapse (multiple suicide attempts or inpatient psychiatric hospitalizations in the past 5 years) - Within past 3 years: Inpatient psychiatric hospitalization - Within past 5 years: Suicide attempt - Declining to provide mental health records, a letter of support from mental health professionals, or consent for verbal consultation with mental health professionals when determined to be essential to evaluation. - Cognitive impairment, if judged to have - Limited capacity to make informed decision about procedure and inability to verbalize an understanding of the surgical procedure, risks and benefits. - Inability to demonstrate an understanding of the permanency of lifestyle change required - History of Anorexia or History of/Active Bulimia: If determined to be of low enough severity not to be a clear contraindication, minimum of 5 years abstinence from bulimia, current moderate to severe binge eating or night eating syndrome - Active or History of Substance Abuse with less than 5 years of abstinence - Current use of anti-tricyclic anti-depressants or steroids, psychiatric medications associated with weight gain. |
结果
主要结果指标
1. Efficacy of Bariatric Embolization procedure: Change in body weight [12 months]